Catherine Skari
-
Jul- 2022 -26 JulyNews
Oxbryta Gets Marketing Authorisation In The UK For Patients With Sickle Cell Disease
Voxelotor, an oral treatment taken once daily, is the first medicine authorized in Great Britain that directly inhibits sickle haemoglobin…
Read More » -
Oct- 2021 -29 OctoberNews
NEWSLETTER | Iranian Blood Transfusion Organization (IBTO) October 2021
In featured news: Transfusion of rare blood units saves two patients’ lives 24th stem cell transplantation in Iran using IBTO-stored…
Read More » -
Feb- 2019 -5 FebruaryEvents
International Thalassaemia Conference 2019 in Bangladesh
The city of Dhaka, Bangladesh hosted on January 28 – 31, 2019 the “International Thalassaemia Conference 2019”, gathering researchers,…
Read More » -
1 February
-
Oct- 2021 -28 October
-
27 OctoberNews
TIF Releases New Scientific Bulletin To Highlight Research On Haemoglobin Disorders
A key objective of the Thalassaemia International Federation is to inform and update regularly the global haemoglobinopathies family, both patients…
Read More » -
Nov- 2018 -17 November
-
Oct- 2021 -27 OctoberNews
COMING UP: 1st Global Forum On Access To Safe Blood Products For Patients In Need Of Regular Transfusion – 5 November 2021
Expected Outcomes An understanding of the strategic vision and goals for blood safety and the protection of the blood supply,…
Read More » -
Dec- 2018 -15 December
-
Oct- 2018 -15 OctoberDelegation Visits 2018
Delegation visit to Serbia – 12 October 2018
In the studies of the late Prof Efremov[1], which included all regions of old Yugoslavia, the carrier rate of…
Read More »
